Adhera Therapeutics, Inc.
DelistedCIK 737207fmd_165EWN3KYKD9Q1WBT9RMTNW51DManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2023, 54 periods
Latest annual · FY2019
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q3 FY2023
Millions- Operating income
- (0)
- Net income
- (4)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2017 to FY2022
- n/m
Adhera Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.6 million | -$674,000 | 10-K 2023-03-31 · proof | |
| Net income | -$2.1 million | -$6.4 million | 10-K 2023-03-31 · proof | |
| Cash from operating activities | -$1.4 million | -$665,000 | 10-K 2023-03-31 · proof | |
| Total assets | $78,511 | $196,000 | -59.9% | 10-Q 2023-11-20 · proof |
| Total liabilities | $22.3 million | $25.3 million | -12% | 10-Q 2023-11-20 · proof |
| Cash and cash equivalents | $32,000 | $76,000 | -57.9% | 10-K 2023-03-31 · proof |
- What was Adhera Therapeutics, Inc.'s operating income in fiscal 2022?
- Adhera Therapeutics, Inc. reported operating income of -$1.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$674,000 the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Adhera Therapeutics, Inc.'s net income in fiscal 2022?
- Adhera Therapeutics, Inc. reported net income of -$2.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$6.4 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Adhera Therapeutics, Inc.'s cash from operating activities in fiscal 2022?
- Adhera Therapeutics, Inc. reported cash from operating activities of -$1.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$665,000 the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What are Adhera Therapeutics, Inc.'s total assets?
- As of Dec 31, 2022, Adhera Therapeutics, Inc. reported total assets of $78,511, against $196,000 a year earlier (-59.9%). Source: the 10-Q filed with the SEC on Nov 20, 2023 (restated). SEC
- What are Adhera Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2022, Adhera Therapeutics, Inc. reported total liabilities of $22.3 million, against $25.3 million a year earlier (-12%). Source: the 10-Q filed with the SEC on Nov 20, 2023 (restated). SEC
- What are Adhera Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Adhera Therapeutics, Inc. reported cash and cash equivalents of $32,000, against $76,000 a year earlier (-57.9%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:737207&period_type=annual&limit=5"Information only, not investment advice.